Skip to search formSkip to main contentSkip to account menu

DAT regimen

Known as: Daunorubicin-AraC-Thioguanine Regimen, Daunorubicin-Cytarabine-Thioguanine Regimen, MRC AML10 Study-DAT Regimen 
A regimen consisting of daunorubicin, cytarabine (Ara-C) and thioguanine, used as an induction treatment for childhood acute myeloid leukemia (AML).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
SUMMARY In this study, we assessed the sensitivity, specificity, and diagnostic accuracy of a previously developed direct… 
2017
2017
This article describes a model Debate Analysis and Findings (DAT) in the yellow book learning in schools to improve students… 
2017
2017
The Russian–Lithuanian cross-border area around the Nemunas and Sesupė rivers confluence is a key area for solving… 
2016
2016
The prevalence of type 2 diabetes mellitus (T2DM), which leads to diabetic complications, has been increasing worldwide. The… 
2003
2003
  • B. Ale
  • 2003
  • Corpus ID: 178528397
Highly Cited
1986
Highly Cited
1986
One patient with acute nonlymphocytic leukemia (ANLL) in remission was given intensive chemotherapy (DAT regimen) as late… 
1983
1983
The EETA79001 meteor i te , found i n An ta r c t i ca i n 1979, has been i d e n t i f i e d as a f o u r t h member o f t h e r…